A RANDOMIZED, 2-ARM, PHASE 3 STUDY OF ELRANATAMAB (PF-06863135) VERSUS LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION
A RANDOMIZED, 2-ARM, PHASE 3 STUDY OF ELRANATAMAB (PF-06863135) VERSUS LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION
The purpose of this study is to evaluate whether elranatamab monotherapy can provide clinical benefit compared to lenalidomide monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Part 1 and Part 2 of the study, participants in the study will either receive elranatamab (arm A and C) as an injection under the skin at the study clinic or lenalidomide orally once daily at home (arm B). Participation in the study will be approximately five years
Elranatamab is a bispecific antibody: binding of elranatamab to CD3-expressing T-cells and BCMA-expressing multiple myeloma cells causes targeted T-cell-mediated cytotoxicity.
Inclusion Criteria:
Exclusion Criteria:
Santa Monica, California 90404, United States
Kansas City, Missouri 64132, United States
Yvoir, Namur 5530, Belgium
Salvador, Estado de Bahia 41253-190, Brazil
Porto Alegre, Rio Grande do Sul 90110-270, Brazil
Ribeirão Preto, São Paulo 14051-140, Brazil
SP, São Paulo 04537-080, Brazil
São Paulo, 01232-010, Brazil
Montreal, Quebec H1T 2M4, Canada
Montreal, Quebec H4J 1C5, Canada
Helsinki, Uusimaa 00029, Finland
Toulouse, Haute-garonne 31100, France
Nyíregyháza, 4400, Hungary
Ramat Gan, Central District 5262100, Israel
Haifa, Northern District 3109601, Israel
Meldola, Emilia-Romagna 47014, Italy
Ancona, 60126, Italy
Yahaba-cho, Iwate 028-3695, Japan
Sunto-gun, Shizuoka 411-8777, Japan
Bunkyo-ku, Tokyo 113-8603, Japan
Warsaw, 02-781, Poland
Namdong-gu, Incheon-gwangyeoksi [incheon] 21565, South Korea
Hwasun Gun, Jeonranamdo 58128, South Korea
Seoul, Seoul-teukbyeolsi [seoul] 06591, South Korea
L'Hospitalet Del Llobregat, Barcelona [barcelona] 08908, Spain
Salamanca, 37007, Spain
Ankara, 06200, Turkey (Türkiye)